DA Davidson lowered the firm’s price target on Natures Sunshine Products to $21 from $23 but keeps a Buy rating on the shares. The company reported a Q2 sales miss due to weak macro, with the strategic initiatives in North America and China that should be beneficial in the second half also seen as “modestly disruptive” in Q2, the analyst tells investors in a research note. Prior-year constant currency sales comps are easier in the second half however, and the firm expects positive growth to resume in Q3 and accelerate in Q4 as the strategic initiatives gain traction, the firm added.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NATR: